Ranibizumab Therapy for Neovascular Age-Related Macular Degeneration.

被引：75
作者：
Folk, James C. [1 ]
Stone, Edwin M. [1 ,2 ]
机构：
[1] Univ Iowa, Carver Coll Med, Dept Ophthalmol & Visual Sci, Iowa City, IA 52242 USA
[2] Univ Iowa, Carver Coll Med, Howard Hughes Med Inst, Iowa City, IA 52242 USA
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2010年 / 363卷 / 17期
关键词：
ENDOTHELIAL GROWTH-FACTOR; COMPLEMENT FACTOR-H; PHOTODYNAMIC THERAPY; MACULOPATHY; MEMBRANES; RISK; VERTEPORFIN; BEVACIZUMAB; LESIONS; PHOTOCOAGULATION;
D O I：
10.1056/NEJMct1000495
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
This Journal feature begins with a case vignette that includes a therapeutic recommendation. A discussion of the clinical problem and the mechanism of benefit of this form of therapy follows. Major clinical studies, the clinical use of this therapy, and potential adverse effects are reviewed. Relevant formal guidelines, if they exist, are presented. The article ends with the authors' clinical recommendations.
引用
收藏
页码：1648 / 1655
页数：8
相关论文
共 49 条
[1]  
[Anonymous], 1991, ARCH OPHTHALMOL, V109, P1242
[2]  
[Anonymous], 1999, ARCH OPHTHALMOL, V117, P1329
[3]  
[Anonymous], 2008, PREF PRACT PATT GUID
[4]   Intravitreal Bevacizumab for Treatment of Neovascular Age-related Macular Degeneration: The Second Year of a Prospective Study [J].
Bashshur, Ziad F. ;
Haddad, Zeina A. ;
Schakal, Alexandre R. ;
Jaafar, Rola F. ;
Saad, Alain ;
Noureddin, Baha' N. .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 2009, 148 (01) :59-65
[5]  
BOK D, 1993, J CELL SCI, P189
[6]   Subgroup analysis of the MARINA study of ranibizumab in neovascular age-related macular degeneration [J].
Boyer, David S. ;
Antoszyk, Andrew N. ;
Awh, Carl C. ;
Bhisitkul, Robert B. ;
Shapiro, Howard ;
Acharya, Nisha R. .
OPHTHALMOLOGY, 2007, 114 (02) :246-252
[7]   Ranibizumab versus verteporfin for neovascular age-related macular degeneration [J].
Brown, David M. ;
Kaiser, Peter K. ;
Michels, Mark ;
Soubrane, Gisele ;
Heier, Jeffrey S. ;
Kim, Robert Y. ;
Sy, Judy P. ;
Schneider, Susan .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (14) :1432-1444
[8]   Ranibizumab versus Verteporfin Photodynamic Therapy for Neovascular Age-Related Macular Degeneration: Two-Year Results of the ANCHOR Study [J].
Brown, David M. ;
Michels, Mark ;
Kaiser, Peter K. ;
Heier, Jeffrey S. ;
Sy, Judy P. ;
Ianchulev, Tsontcho .
OPHTHALMOLOGY, 2009, 116 (01) :57-65
[9]  
Brown Gary C, 2005, Trans Am Ophthalmol Soc, V103, P173
[10]   A value-based medicine analysis of ranibizumab for the treatment of subfoveal neovascular macular degeneration [J].
Brown, Melissa M. ;
Brown, Gary C. ;
Brown, Heidi C. ;
Peet, Jonathan .
OPHTHALMOLOGY, 2008, 115 (06) :1039-1045
12345